Silverfin false false 30/04/2025 01/05/2024 30/04/2025 Ramy Aboushelbaya 30/04/2020 Janet Collyer 01/03/2022 Marko Von Der Leyen 05/07/2021 IP2IPO Services Limited 05/07/2021 Elaia Partners 05/07/2021 03 July 2026 The principal activity of the company continued to be that of development and manufacturing of electronic components. 12579596 2025-04-30 12579596 bus:Director1 2025-04-30 12579596 bus:Director2 2025-04-30 12579596 bus:Director3 2025-04-30 12579596 bus:Director4 2025-04-30 12579596 bus:Director5 2025-04-30 12579596 2024-04-30 12579596 core:CurrentFinancialInstruments 2025-04-30 12579596 core:CurrentFinancialInstruments 2024-04-30 12579596 core:ShareCapital 2025-04-30 12579596 core:ShareCapital 2024-04-30 12579596 core:SharePremium 2025-04-30 12579596 core:SharePremium 2024-04-30 12579596 core:OtherCapitalReserve 2025-04-30 12579596 core:OtherCapitalReserve 2024-04-30 12579596 core:RetainedEarningsAccumulatedLosses 2025-04-30 12579596 core:RetainedEarningsAccumulatedLosses 2024-04-30 12579596 2023-04-30 12579596 core:OtherResidualIntangibleAssets 2024-04-30 12579596 core:OtherResidualIntangibleAssets 2025-04-30 12579596 core:OtherPropertyPlantEquipment 2024-04-30 12579596 core:OtherPropertyPlantEquipment 2025-04-30 12579596 bus:OrdinaryShareClass1 2025-04-30 12579596 bus:OrdinaryShareClass2 2025-04-30 12579596 bus:OrdinaryShareClass3 2025-04-30 12579596 bus:OrdinaryShareClass4 2025-04-30 12579596 2024-05-01 2025-04-30 12579596 bus:FilletedAccounts 2024-05-01 2025-04-30 12579596 bus:SmallEntities 2024-05-01 2025-04-30 12579596 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 12579596 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 12579596 bus:Director1 2024-05-01 2025-04-30 12579596 bus:Director2 2024-05-01 2025-04-30 12579596 bus:Director3 2024-05-01 2025-04-30 12579596 bus:Director4 2024-05-01 2025-04-30 12579596 bus:Director5 2024-05-01 2025-04-30 12579596 core:OtherResidualIntangibleAssets core:TopRangeValue 2024-05-01 2025-04-30 12579596 core:PatentsTrademarksLicencesConcessionsSimilar 2024-05-01 2025-04-30 12579596 core:OtherPropertyPlantEquipment 2024-05-01 2025-04-30 12579596 2023-05-01 2024-04-30 12579596 core:OtherResidualIntangibleAssets 2024-05-01 2025-04-30 12579596 bus:OrdinaryShareClass1 2024-05-01 2025-04-30 12579596 bus:OrdinaryShareClass1 2023-05-01 2024-04-30 12579596 bus:OrdinaryShareClass2 2024-05-01 2025-04-30 12579596 bus:OrdinaryShareClass2 2023-05-01 2024-04-30 12579596 bus:OrdinaryShareClass3 2024-05-01 2025-04-30 12579596 bus:OrdinaryShareClass3 2023-05-01 2024-04-30 12579596 bus:OrdinaryShareClass4 2024-05-01 2025-04-30 12579596 bus:OrdinaryShareClass4 2023-05-01 2024-04-30 12579596 1 2024-05-01 2025-04-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 12579596 (England and Wales)

QUANTUM DICE LIMITED

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 30 APRIL 2025
PAGES FOR FILING WITH THE REGISTRAR

QUANTUM DICE LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 30 APRIL 2025

Contents

QUANTUM DICE LIMITED

BALANCE SHEET

AS AT 30 APRIL 2025
QUANTUM DICE LIMITED

BALANCE SHEET (continued)

AS AT 30 APRIL 2025
Note 2025 2024
£ £
Fixed assets
Intangible assets 5 14,025 0
Tangible assets 6 49,741 47,087
63,766 47,087
Current assets
Debtors 7 346,746 57,944
Investments 0 4,298
Cash at bank and in hand 2,812,936 378,548
3,159,682 440,790
Creditors: amounts falling due within one year 8, 12 ( 168,832) ( 690,653)
Net current assets/(liabilities) 2,990,850 (249,863)
Total assets less current liabilities 3,054,616 (202,776)
Net assets/(liabilities) 3,054,616 ( 202,776)
Capital and reserves
Called-up share capital 9 442 263
Share premium account 6,535,688 2,434,682
Other reserves 6,498 0
Profit and loss account ( 3,488,012 ) ( 2,637,721 )
Total shareholders' funds/(deficit) 3,054,616 ( 202,776)

For the financial year ending 30 April 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Quantum Dice Limited (registered number: 12579596) were approved and authorised for issue by the Board of Directors on 03 July 2026. They were signed on its behalf by:

Ramy Aboushelbaya
Director
QUANTUM DICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 30 APRIL 2025
QUANTUM DICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 30 APRIL 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Quantum Dice Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 264 Banbury Road, Oxford, OX2 7DY, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Group accounts exemption

Group accounts exemption s399
The Company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the Company as an individual entity and not about its group.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Employee benefits

Short term benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed asset.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised as an expense when the Company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Share-based payment

Equity-settled share-based payment transactions are measured at fair value at the date of grant. The fair value determined at the grant date of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period, based on the Company's estimate of shares that will eventually vest and adjusted for the effect of non-market-based vesting conditions.

Fair value is measured by use of the Black Scholes model which is considered by management to be the most appropriate method of valuation. The expected life used in the model has been adjusted, based on management’s best estimate, for the effects of non-transferability, exercise restrictions, and behavioural considerations.

Cancellations or settlements (including those resulting from employee redundancies) are treated as an acceleration of vesting and the amount that would have been recognised over the remaining vesting period is recognised immediately.

Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Other intangible assets 10 years straight line
Trademarks, patents and licences

Separately acquired patents and trademarks are included at cost and amortised in equal annual instalments over a period of 10 years which is their estimated useful economic life. Amortisation commences once a patent is available for use in the commercial generation of revenue. Provision is made for any impairment.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 15 % reducing balance

Depreciation methods, useful lives and residual values are reviewed at each balance sheet date. The selection of these residual values and estimated lives requires the exercise of judgement. The directors are required to assess whether there is an indication of impairment to the carrying value of assets. In making that assessment, judgements are made in estimating value in use. The directors consider that the individual carrying values of assets are supportable by their value in use.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Profit and Loss Account over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

Convertible loan notes
The component parts of compound instruments issued by the Company are classified separately as financial liabilities and equity in accordance with the substance of the contractual arrangement. On initial recognition, the financial liability component is recorded at its fair value (See note 11).

Transaction costs are apportioned between the liability and equity components of the convertible instrument based on their relative fair values at the date of issue. The portion relating to the equity component is charged directly against equity.

Fair value measurement
The best evidence of fair value is a quoted price for an identical asset in an active market. When quoted prices are unavailable, the price of a recent transaction for an identical asset provides evidence of fair value as long as there has not been a significant change in economic circumstances or a significant lapse of time since the transaction took place. If the market is not active and recent transactions of an identical asset on their own are not a good estimate of fair value, the fair value is estimated by using a valuation techniques which consider market factors.

Government grants

Government grants are recognised based on the performance model and are measured at the fair value of the asset received or receivable when there is reasonable assurance that the Company will comply with conditions attaching to them and the grants will be received.

A grant that specifies performance conditions is recognised in income only when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the grant proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2. Critical accounting judgements and key sources of estimation uncertainty

The preparation of financial statements requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the company accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed within the individual accounting policies below.

3. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 19 20

4. Share-based payments

Equity-settled share-based payment schemes

The Company has a share option scheme for all employees.

The options outstanding at the period end had an exercise price of £1.00. 16,721 options had a remaining contractual life of 8 years.

Details of the share options outstanding during the financial year are as follows:

2025 2024
Weighted Average Weighted Average
Number of share options Average exercise price (£) Number of share options Average exercise price (£)
Outstanding at beginning of period 16,721 1.00 1,010 1.00
Granted during the period 0 0 15,711 1.00
Outstanding at the end of the period 16,721 1.00 16,721 1.00
Exercisable at the end of the period 0 0 0 0

The fair value of the share options at the grant date was calculated using the Black Scholes model, which is considered to be the most appropriate generally accepted valuation method of measuring fair value.

The Company recognised total expenses of £ 6,498 and £ 0 related to equity-settled share-based payment transactions in 2025 and 2024 respectively.

5. Intangible assets

Other intangible assets Total
£ £
Cost
At 01 May 2024 0 0
Additions 14,025 14,025
At 30 April 2025 14,025 14,025
Accumulated amortisation
At 01 May 2024 0 0
At 30 April 2025 0 0
Net book value
At 30 April 2025 14,025 14,025
At 30 April 2024 0 0

6. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 May 2024 60,537 60,537
Additions 10,231 10,231
Disposals ( 322) ( 322)
At 30 April 2025 70,446 70,446
Accumulated depreciation
At 01 May 2024 13,450 13,450
Charge for the financial year 7,383 7,383
Disposals ( 128) ( 128)
At 30 April 2025 20,705 20,705
Net book value
At 30 April 2025 49,741 49,741
At 30 April 2024 47,087 47,087

7. Debtors

2025 2024
£ £
Trade debtors 39,521 4,799
Amounts owed by Group undertakings 0 4,311
Corporation tax 232,416 0
Other debtors 74,809 48,834
346,746 57,944

8. Creditors: amounts falling due within one year

2025 2024
£ £
Trade creditors 48,878 48,876
Other taxation and social security 37,968 80,911
Other creditors 81,986 560,866
168,832 690,653

9. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
149,779 A1-A ordinary shares of £ 0.001 each (2024: nil shares) 149.78 0
29,605 A1-B ordinary shares of £ 0.001 each (2024: nil shares) 29.61 0
162,740 A2 ordinary shares of £ 0.001 each 162.74 162.74
100,000 Ordinary shares of £ 0.001 each 100.00 100.00
442.13 262.74

10. Related party transactions

Transactions with entities in which the entity itself has a participating interest

2025 2024
£ £
Quantum Dice Europe 413 2,510

During the year Quantum Dice Limited settled expenses on behalf of Quantum Dice Europe totalling £413 (2024: £2,510).

11. Events after the Balance Sheet date

Subsequent to the balance sheet date, the company secured a €1,962,056 grant from the European Innovation Council (EIC) Accelerator programme.

This funding is intended to support the company’s development and commercialisation of its probabilistic computing platform. As this event occurred after the reporting period, it represents a non-adjusting post-balance sheet event, and no adjustments have been made to the amounts recognised in the financial statements for the year.

12. Convertible loan notes

Reconciliation of changes in equity

2025 2024
£ £
Fair value of convertible loan notes 0 488,759

On 23 November 2022, the company issued unsecured loan notes totalling £500,000. While the loan notes have a stated maturity date, the company does not expect them to be repaid in cash at maturity. Instead, it is anticipated that the loan notes will convert into equity shares upon the occurrence of an an adjustment event, specifically the issue of new equity by the company, as detailed in the loan note agreement. As such, the loan notes have been recognised at fair value through profit or loss.

From the effective date until the 12 month anniversary of the effective date, no interest was payable on these convertible loan notes. From the first day after this interest free period until the conversion date, simple interest was payable at 1.5% per month.

On 19th August 2024, all outstanding convertible loan notes were converted into 29,605 A1-b ordinary shares.